drugset
Drugs / autologous adipose tissue-derived stromal vascular fraction cells
last change Oct 2025 re-read 3 minutes ago

autologous adipose tissue-derived stromal vascular fraction cells

Cell therapy

Developed for
osteoarthritis, knee
Investigated by
Hospital Vivian Pellas, Nicaragua · Michael H Carstens · Ministry of Health Nicaragua · University of California, San Francisco · Wake Forest University

Trials 1

today NCT07259993 · Ph 1/2
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT07259993 Aug 2013 → Jul 2025 osteoarthritis, knee Michael H Carstens Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as autologous adipose tissue-derived stromal vascular fraction cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT07259993 ↗
Modality Cell therapy “adipose-derived stromal vascular fraction cell components” NCT07259993 ↗
Route Other “intra-articular injection into knees” NCT07259993 ↗